The changing face of breast cancer - past, present and future perspectives
Tamoxifen - an update on current data and where it can now be used
New generation aromatase inhibitors - from the advanced to the adjuvant setting
A new estrogen receptor antagonist - an overview of available data
Overview of luteinizing hormone-releasing hormone agonists in early breast cancer - benefits of reversible ovarian ablation
Sequencing of endocrine therapies in breast cancer - integration of recent data
Panel discussion one: The changing face of breast cancer - meeting the challenges
Choosing between endocrine therapy and chemotherapy - or is there a role for combination therapy?
Issues and challenges for antiangiogenic therapies
The role of EGFR-directed therapy in the treatment of breast cancer
Panel discussion two: The changing face of breast cancer - meeting the challenges
The status of breast cancer management: challenges and opportunities
Announcement